Logo image
Utility of Commercial Systems for Identification of Burkholderia cepacia Complex from Cystic Fibrosis Sputum Culture
Journal article   Open access   Peer reviewed

Utility of Commercial Systems for Identification of Burkholderia cepacia Complex from Cystic Fibrosis Sputum Culture

Deborah Blecker Shelly, Theodore Spilker, Edward J Gracely, Tom Coenye, Peter Vandamme and John J LiPuma
Journal of clinical microbiology, v 38(8), pp 3112-3115
Aug 2000
PMID: 10921992
url
https://doi.org/10.1128/JCM.38.8.3112-3115.2000View
Published, Version of Record (VoR) Open

Abstract

Bacteriology
Performances of several commercial test systems were reviewed to determine their relative levels of accuracy in identifying Burkholderia cepacia complex isolates recovered from cystic fibrosis sputum culture. Positive predictive values ranged from 71 to 98%; negative predictive values ranged from 50 to 82%. All systems misidentified B. cepacia complex. The species most frequently misidentified as B. cepacia was Burkholderia gladioli . These data support the results of previous studies that recommend confirmatory testing, including the use of DNA-based methods, for sputum culture isolates presumptively identified as B. cepacia .

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Microbiology
Logo image